Online citations, reference lists, and bibliographies.
← Back to Search

Resistance Mechanisms Associated With Altered Intracellular Distribution Of Anticancer Agents.

A. Larsen, A. Escargueil, A. Skladanowski
Published 2000 · Medicine, Biology

Cite This
Download PDF
Analyze on Scholarcy
Share
The resistance of tumor cells to anticancer agents remains a major cause of treatment failure in cancer patients. The term multidrug resistance (MDR) is used to define a resistance phenotype where cells are resistant to multiple drugs with no obvious structural resemblance and with different molecular targets. It is now clear that MDR is always multifactorial. The intracellular drug distribution is modified in many MDR cell lines, leading to increased drug sequestration in acidic vesicles, such as the trans-Golgi apparatus, recycling endosomes, and lysosomes, followed by transport to the plasma membrane and extrusion into the external medium. Since most anticancer agents target DNA or nuclear enzymes, sequestration of drug in cytoplasmic organelles will lead to decreased drug-target interaction and thereby, decreased cytotoxicity. Altered intracellular drug distribution is usually associated with the expression of drug efflux pumps, such as the P-glycoprotein and the multidrug resistance protein. Another common modification in MDR cells is alkalization of the intracellular pH. The relationship between these different resistance mechanisms is reviewed and a model proposed that suggests why these different resistance mechanisms are co-expressed in multiple cell lines.
This paper references
Transport of sphingomyelin to the cell surface is inhibited by brefeldin A and in mitosis, where C6-NBD-sphingomyelin is translocated across the plasma membrane by a multidrug transporter activity.
A. van Helvoort (1997)
Synthetic and natural opiates interact with P-glycoprotein in multidrug-resistant cells.
R. Callaghan (1993)
10.1002/(SICI)1097-0215(19980330)76:1<55::AID-IJC10>3.0.CO;2-F
Transport of glutathione conjugates into secretory vesicles is mediated by the multidrug‐resistance protein 1
M. van Luyn (1998)
Certain calcium channel blockers bind specifically to multidrug-resistant human KB carcinoma membrane vesicles and inhibit drug binding to P-glycoprotein.
M. M. Cornwell (1987)
10.1016/0006-2952(88)90643-0
The carboxylic ionophore monensin inhibits active drug efflux and modulates in vitro resistance in daunorubicin resistant Ehrlich ascites tumor cells.
M. Sehested (1988)
10.1073/PNAS.96.9.5310
The first-nucleotide binding domain of the cystic-fibrosis transmembrane conductance regulator is important for inhibition of the epithelial Na+ channel.
R. Schreiber (1999)
10.1038/bjc.1997.338
Characterization of a clonal human colon adenocarcinoma line intrinsically resistant to doxorubicin.
E. Dolfini (1997)
Intracellular distribution and pharmacokinetics of daunorubicin in anthracycline-sensitive and -resistant HL-60 cells.
A. Hindenburg (1989)
Subcellular distribution of daunorubicin in P-glycoprotein-positive and -negative drug-resistant cell lines using laser-assisted confocal microscopy.
J. E. Gervasoni (1991)
10.1038/NM1197-1275
Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein
J. Wijnholds (1997)
10.1038/bjc.1993.244
Examination by laser scanning confocal fluorescence imaging microscopy of the subcellular localisation of anthracyclines in parent and multidrug resistant cell lines.
H. Coley (1993)
10.1021/BI970530G
Analysis of ion transport perturbations caused by hu MDR 1 protein overexpression.
M. Hoffman (1997)
10.1084/JEM.187.10.1583
Defective Acidification in Human Breast Tumor Cells and Implications for Chemotherapy
N. Altan (1998)
The human multidrug resistance protein MRP1 translocates sphingolipid analogs across the plasma membrane.
R. Raggers (1999)
Uptake of adriamycin by rat and mouse mast cells and correlation with histamine release.
G. Decorti (1989)
The effect of lysosomotropic agents and secretory inhibitors on anthracycline retention and activity in multiple drug-resistant cells.
W. Klohs (1988)
10.1002/IJC.2910520125
P‐glycoprotein transports corticosterone and is photoaffinity‐labeled by the steroid
D. C. Wolf (1992)
10.1093/JNCI/78.1.171
Increase in nonspecific adsorptive endocytosis in anthracycline- and vinca alkaloid-resistant Ehrlich ascites tumor cell lines.
M. Sehested (1987)
10.1007/s004360050365
Identification of three ABC transporter genes in Trypanosomabrucei spp.
P. Mäser (1997)
Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells.
Y. Cui (1999)
10.1016/S0006-2952(99)00022-2
pH and drug resistance. I. Functional expression of plasmalemmal V-type H+-ATPase in drug-resistant human breast carcinoma cell lines.
R. Martínez-Zaguilán (1999)
10.1016/0092-8674(90)90206-T
Microtubules, membrane traffic, and cell organization
R. Kelly (1990)
10.1152/AJPCELL.1993.265.4.C1015
Vacuolar-type H(+)-ATPases are functionally expressed in plasma membranes of human tumor cells.
R. Martínez-Zaguilán (1993)
10.1073/PNAS.91.19.8822
The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump.
G. Zaman (1994)
10.1111/j.1365-2818.1994.tb03516.x
Intracellular localization of the antitumour drug adriamycin in living cultured cells: A confocal microscopy study
S. Meschini (1994)
10.1016/S0092-8674(00)81370-7
MDR1 P-Glycoprotein Is a Lipid Translocase of Broad Specificity, While MDR3 P-Glycoprotein Specifically Translocates Phosphatidylcholine
A. V. Helvoort (1996)
10.1016/0006-2952(96)00450-9
Multidrug resistance mediated by the multidrug resistance protein (MRP) gene.
D. Lautier (1996)
10.1038/sj.leu.2400557
Co-expression of several molecular mechanisms of multidrug resistance and their significance for paclitaxel cytotoxicity in human AML HL-60 cells
Y. Huang (1997)
10.1002/(SICI)1521-1878(199811)20:11<931::AID-BIES8>3.0.CO;2-J
Multidrug resistance mediated by the ATP‐binding cassette transporter protein MRP
S. Cole (1998)
10.1002/(SICI)1097-0215(19980316)75:6<885::AID-IJC11>3.0.CO;2-2
Detection of P‐glycoprotein in the Golgi apparatus of drug‐untreated human melanoma cells
A. Molinari (1998)
10.1002/j.1460-2075.1995.tb06976.x
Protein kinase C‐mediated phosphorylation of the human multidrug resistance P‐glycoprotein regulates cell volume‐activated chloride channels.
S. P. Hardy (1995)
10.1124/MOL.51.6.1034
ATP-dependent transport of aflatoxin B1 and its glutathione conjugates by the product of the multidrug resistance protein (MRP) gene.
D. Loe (1997)
Nuclear pH gradient in mammalian cells revealed by laser microspectrofluorimetry.
O. Seksek (1996)
10.1016/0959-8049(96)00053-6
Major vault protein LRP-related multidrug resistance.
M. A. Izquierdo (1996)
Tissue distribution of the multidrug resistance protein.
M. Flens (1996)
10.1073/PNAS.95.12.7024
The drug efflux protein, P-glycoprotein, additionally protects drug-resistant tumor cells from multiple forms of caspase-dependent apoptosis.
M. Smyth (1998)
10.1038/NM0496-467
Aminoglycoside antibiotics restore CFTR function by overcoming premature stop mutations
M. Howard (1996)
10.1038/bjc.1995.281
Regulation by glutathione of drug transport in multidrug-resistant human lung tumour cell lines overexpressing multidrug resistance-associated protein.
C. Versantvoort (1995)
10.1016/0959-8049(95)00606-0
Effect of intracellular acidity and ionomycin on apoptosis in HL-60 cells.
H. Park (1996)
10.1182/BLOOD.V94.3.1046.415K03_1046_1056
Simultaneous activity of MRP1 and Pgp is correlated with in vitro resistance to daunorubicin and with in vivo resistance in adult acute myeloid leukemia.
O. Legrand (1999)
Expression of multidrug resistance-associated protein in NIH/3T3 cells confers multidrug resistance associated with increased drug efflux and altered intracellular drug distribution.
L. M. Breuninger (1995)
10.1016/0014-5793(95)00677-2
ATP‐dependent efflux of calcein by the multidrug resistance protein (MRP): no inhibition by intracellular glutathione depletion
N. Feller (1995)
10.1074/jbc.273.15.8971
Vaults Are Up-regulated in Multidrug-resistant Cancer Cell Lines*
V. Kickhoefer (1998)
The inventory of all ion and drug ATPases encoded by the yeast genome.
A. Goffeau (1998)
10.1016/S0167-4781(98)00140-7
Cellular resistance to topoisomerase-targeted drugs: from drug uptake to cell death.
A. Larsen (1998)
10.1021/BI00092A014
Lower electrical membrane potential and altered pHi homeostasis in multidrug-resistant (MDR) cells: further characterization of a series of MDR cell lines expressing different levels of P-glycoprotein.
P. Roepe (1993)
10.1016/0005-2736(76)90160-7
A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants.
R. Juliano (1976)
10.1093/JNCI/83.15.1098
Involvement of vacuolar H(+)-adenosine triphosphatase activity in multidrug resistance in HL60 cells.
D. Marquardt (1991)
10.1073/PNAS.94.8.4028
Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins.
A. Schinkel (1997)
10.1016/S0005-2728(98)00039-5
The ABC family of multidrug transporters in microorganisms.
H. V. van Veen (1998)
Drug transport mechanisms in HL60 cells isolated for resistance to adriamycin: evidence for nuclear drug accumulation and redistribution in resistant cells.
D. Marquardt (1992)
10.1074/jbc.274.16.10877
Intracellular pH and Multidrug Resistance Regulate Complement-mediated Cytotoxicity of Nucleated Human Cells*
J. Weisburg (1999)
10.1038/bjc.1987.282
Increased plasma membrane traffic in daunorubicin resistant P388 leukaemic cells. Effect of daunorubicin and verapamil.
M. Sehested (1987)
A canalicular multispecific organic anion transporter (cMOAT) antisense cDNA enhances drug sensitivity in human hepatic cancer cells.
K. Koike (1997)
10.1085/JGP.108.4.295
Are altered pHi and membrane potential in hu MDR 1 transfectants sufficient to cause MDR protein-mediated multidrug resistance?
M. Hoffman (1996)
10.1016/0304-3940(94)90330-1
The aminoglycoside G418 suppresses muscarinic receptor-activated calcium release in stably transfected murine N1E-115 neuroblastoma cells
J. S. Coggan (1994)
10.1021/BI00481A013
The carboxy terminus of the alpha subunit of tubulin regulates its interaction with colchicine.
Kasturi Mukhopadhyay (1990)
10.1073/PNAS.96.12.6914
MRP3, an organic anion transporter able to transport anti-cancer drugs.
M. Kool (1999)
Characterization of the Mr 190,000 Multidrug Resistance Protein (MRP) in Drug-selected and Transfected Human Tumor Cells
K. Almquist (1995)
10.1002/IJC.2910590614
P‐glycoprotein expression in the Golgi apparatus of multidrug‐resistant cells
A. Molinari (1994)
10.1074/JBC.270.10.4967
Direct Measurement of trans-Golgi pH in Living Cells and Regulation by Second Messengers (*)
O. Seksek (1995)
10.1182/BLOOD.V89.10.3745.3745_3745_3754
Vesicular anthracycline accumulation in doxorubicin-selected U-937 cells: participation of lysosomes.
S. Hurwitz (1997)
10.1038/355641A0
Assembly and function of the two ABC transporter proteins encoded in the human major histocompatibility complex
A. Kelly (1992)
10.1002/JCP.1041490326
Gene activation mediated by protein kinase C in human macrophage and teratocarcinoma cells expressing aminoglycoside phosphotransferase activity
J. Maio (1991)
10.1016/S1359-6446(98)01276-8
Role of organelle pH in tumor cell biology and drug resistance.
V. Simon (1999)
10.1177/35.12.2890686
Immunocytochemical localization of P170 at the plasma membrane of multidrug-resistant human cells.
M. Willingham (1987)
Expression of human MRP6, a homologue of the multidrug resistance protein gene MRP1, in tissues and cancer cells.
M. Kool (1999)
10.1038/sj.leu.2401166
Characterization of H+-ATPase-dependent activity of multidrug resistance-associated protein in homoharringtonine-resistant human leukemic K562 cells
Z. Benderra (1998)
Characterization of vincristine transport by the M(r) 190,000 multidrug resistance protein (MRP): evidence for cotransport with reduced glutathione.
D. Loe (1998)
Alterations in glutathione and glutathione-related enzymes in a multidrug-resistant small cell lung cancer cell line.
S. Cole (1990)
Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs.
C. Grant (1994)
10.1074/jbc.274.19.12951
Structure and Properties of the Vacuolar (H+)-ATPases*
M. Forgac (1999)
10.1002/(SICI)1097-0215(19990517)81:4<580::AID-IJC13>3.0.CO;2-T
Alteration of the daunorubicin‐triggered sphingomyelin‐ceramide pathway and apoptosis in MDR cells: Influence of drug transport abnormalities
M. Côme (1999)
10.1007/BF00686560
The structure of P-glycoprotein and the secretion of lysosomal enzymes in multidrug-resistant cells
L. Warren (2004)
10.1016/S0006-2952(98)00306-2
Plasmalemmal pH-gradients in drug-sensitive and drug-resistant MCF-7 human breast carcinoma xenografts measured by 31P magnetic resonance spectroscopy.
N. Raghunand (1999)
Energy-dependent accumulation of daunorubicin into subcellular compartments of human leukemia cells and cytoplasts.
C. Slapak (1992)
10.1002/JCP.1040880104
Pleiotropic phenotype of colchicine‐resistant CHO cells: Cross‐resistance and collateral sensitivity
N. T. Bech-Hansen (1976)
Secretion of lysosomal enzymes by drug-sensitive and multiple drug-resistant cells.
L. Warren (1991)
Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells.
S. Cole (1994)
10.1074/jbc.270.7.3462
Functional studies of P-glycoprotein in inside-out plasma membrane vesicles derived from murine erythroleukemia cells overexpressing MDR 3.
S. Schlemmer (1995)
10.1038/sj.bjc.6690174
Dual mechanism of daunorubicin-induced cell death in both sensitive and MDR-resistant HL-60 cells
M. Côme (1999)
10.3892/IJO.12.3.711
Role of the vacuolar H+-ATPase in daunorubicin distribution in etoposide-resistant MCF7 cells overexpressing the multidrug-resistance associated protein.
Z. Benderra (1998)
10.1083/JCB.134.6.1387
Dynamic measurement of the pH of the Golgi complex in living cells using retrograde transport of the verotoxin receptor
J. Kim (1996)
10.1126/SCIENCE.1360704
Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line.
S. Cole (1992)
10.1096/fasebj.8.10.7914178
Interaction of bioactive hydrophobic peptides with the human multidrug transporter
B. Sarkadi (1994)
10.1002/HEP.510230519
Absence of the canalicular isoform of the MRP gene–encoded conjugate export pump from the hepatocytes in Dubin‐Johnson syndrome
J. Kartenbeck (1996)
Effect of alkaline pH on taxol-microtubule interactions.
I. Ringel (1991)
Fluorescent cellular indicators are extruded by the multidrug resistance protein.
L. Homolya (1993)
Expression of the MRP and MDR1 multidrug resistance genes in small cell lung cancer.
B. Campling (1997)
10.1124/MOL.52.3.344
Pharmacological characterization of the murine and human orthologs of multidrug-resistance protein in transfected human embryonic kidney cells.
B. Stride (1997)
10.1021/BI9627830
Human MDR 1 protein overexpression delays the apoptotic cascade in Chinese hamster ovary fibroblasts.
L. Robinson (1997)
10.1126/SCIENCE.2475911
Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.
J. Riordan (1989)
10.1016/0006-2952(95)02026-8
Localisation of the multidrug resistance-associated protein, MRP, in resistant large-cell lung tumour cells.
M. Barrand (1995)
10.1016/S0006-2952(99)00074-X
New insights into the biology and pharmacology of the multidrug resistance protein (MRP) from gene knockout models.
G. Rappa (1999)
d,l-buthionine-(S,R)-sulfoximine potentiates in vivo the therapeutic efficacy of doxorubicin against multidrug resistance protein-expressing tumors.
U. Vanhoefer (1996)
10.1056/NEJM199703063361005
Familial persistent hyperinsulinemic hypoglycemia of infancy and mutations in the sulfonylurea receptor.
M. J. Dunne (1997)
10.1016/S0006-2952(96)00561-8
Increased efflux of vincristine, but not of daunorubicin, associated with the murine multidrug resistance protein (MRP).
C. Slapak (1996)
10.1016/0006-2952(94)90112-0
Sequestration of doxorubicin in vesicles in a multidrug-resistant cell line (LZ-100).
M. Sognier (1994)
10.1021/BI952234E
Defective pH regulation of acidic compartments in human breast cancer cells (MCF-7) is normalized in adriamycin-resistant cells (MCF-7adr).
Melvin Schindler (1996)
10.1016/S0065-2571(98)00015-6
Export pumps for anionic conjugates encoded by MRP genes.
D. Keppler (1999)
ATP-Dependent efflux of CPT-11 and SN-38 by the multidrug resistance protein (MRP) and its inhibition by PAK-104P.
Z. Chen (1999)
Circumvention of vincristine and Adriamycin resistance in vitro and in vivo by calcium influx blockers.
T. Tsuruo (1983)
10.1083/JCB.141.6.1301
Interaction of Vault Particles with Estrogen Receptor in the MCF-7 Breast Cancer Cell
C. Abbondanza (1998)
10.1111/J.1432-1033.1997.00115.X
P-glycoprotein-mediated Hoechst 33342 transport out of the lipid bilayer.
A. B. Shapiro (1997)
10.1016/0092-8674(89)90330-9
Amplification of the multidrug resistance gene in some chloroquine-resistant isolates of P. falciparum
S. Foote (1989)
10.1093/JNCI/91.19.1647
Multidrug resistance and the lung resistance-related protein in human colon carcinoma SW-620 cells.
M. Kitazono (1999)
10.1016/S0006-2952(99)00021-0
pH and drug resistance. II. Turnover of acidic vesicles and resistance to weakly basic chemotherapeutic drugs.
N. Raghunand (1999)
10.1042/BJ3380393
Canalicular multispecific organic anion transporter/multidrug resistance protein 2 mediates low-affinity transport of reduced glutathione
C. Paulusma (1999)
Immunochemical detection of the multidrug resistance-associated protein MRP in human multidrug-resistant tumor cells by monoclonal antibodies.
M. Flens (1994)
Inwardly rectifying K+ channels and volume-regulated anion channels in multidrug-resistant small cell lung cancer cells.
J. Jirsch (1993)
Differential effects of P-glycoprotein inhibitors on NIH3T3 cells transfected with wild-type (G185) or mutant (V185) multidrug transporters.
C. Cardarelli (1995)
The MRP gene associated with a non-P-glycoprotein multidrug resistance encodes a 190-kDa membrane bound glycoprotein.
N. Krishnamachary (1993)
10.1007/BF00191362
Intracellular localization, vesicular accumulation and kinetics of daunorubicin in sensitive and multidrug-resistant gastric carcinoma EPG85-257 cells
A. Seidel (2004)
10.1073/PNAS.96.10.5734
CpABC, a Cryptosporidium parvum ATP-binding cassette protein at the host-parasite boundary in intracellular stages.
M. Perkins (1999)
Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump.
G. Jedlitschky (1996)
10.1038/34669
A bacterial antibiotic-resistance gene that complements the human multidrug-resistance P-glycoprotein gene
H. V. Veen (1998)
10.1038/348637A0
Protein kinase A regulates chloride conductance in endocytic vesicles from proximal tubule
Hae-Rahn Bae (1990)
10.1074/JBC.270.7.3203
Apoptosis in an Interleukin-2-dependent Cytotoxic T Lymphocyte Cell Line Is Associated with Intracellular Acidification
Jian Li (1995)
10.1002/(SICI)1097-0215(19990331)81:1<81::AID-IJC15>3.0.CO;2-P
Characterization of intracellular pH gradients in human multidrug‐resistant tumor cells by means of scanning microspectrofluorometry and dual‐emission‐ratio probes
R. Belhoussine (1999)
Vinblastine photoaffinity labeling of a high molecular weight surface membrane glycoprotein specific for multidrug-resistant cells.
A. Safa (1986)
Intracellular expression of P-glycoprotein in a human colon tumor cell line.
Duensing Td (1994)
10.1016/0006-291X(92)91785-O
The gene encoding vacuolar H(+)-ATPase subunit C is overexpressed in multidrug-resistant HL60 cells.
L. Ma (1992)
10.1073/PNAS.90.20.9735
Changes in intra- or extracellular pH do not mediate P-glycoprotein-dependent multidrug resistance.
G. Altenberg (1993)
10.1073/PNAS.84.9.3004
Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine.
K. Ueda (1987)
10.1083/JCB.108.2.377
Low cytoplasmic pH inhibits endocytosis and transport from the trans- Golgi network to the cell surface
P. Cosson (1989)



This paper is referenced by
10.1016/J.YEXCR.2004.02.009
Ribosomal proteins S13 and L23 promote multidrug resistance in gastric cancer cells by suppressing drug-induced apoptosis.
Y. Shi (2004)
10.7282/T35M64D5
TARGETED NANOMEDICINE PLATFORM FOR CANCER STEM CELLS SPECIFIC THERAPY
Vatsal Shah (2013)
10.14800/CCM.807
The role of cytoplasmic-to-lysosomal pH gradient in hydrophobic weak base drug sequestration in lysosomes
B. Zhitomirsky (2015)
10.1038/cddis.2012.30
Imidazoacridinone-dependent lysosomal photodestruction: a pharmacological Trojan horse approach to eradicate multidrug-resistant cancers
Y. Adar (2012)
10.1016/j.cbi.2020.109138
Can image analysis provide evidence that lysosomal sequestration mediates daunorubicin resistance?
Petr Mlejnek (2020)
10.1007/s13277-014-2873-1
High CHMP4B expression is associated with accelerated cell proliferation and resistance to doxorubicin in hepatocellular carcinoma
Baoying Hu (2014)
10.1248/CPB.C12-00967
Inhibition of P-glycoprotein mediated multidrug resistance by stemofoline derivatives.
Sonthaya Umsumarng (2013)
10.1098/rsif.2009.0166.focus
Bio-metals imaging and speciation in cells using proton and synchrotron radiation X-ray microspectroscopy
R. Ortega (2009)
10.1038/onc.2012.183
LASS2 enhances chemosensitivity of breast cancer by counteracting acidic tumor microenvironment through inhibiting activity of V-ATPase proton pump
S. Fan (2013)
10.1023/B:PHAM.0000012148.12516.3f
A Cell Fractionation Approach for the Quantitative Analysis of Subcellular Drug Disposition
Muralikrishna Duvvuri (2004)
10.1093/JAC/DKG225
Antibiotic efflux pumps in eukaryotic cells: occurrence and impact on antibiotic cellular pharmacokinetics, pharmacodynamics and toxicodynamics.
F. Van Bambeke (2003)
10.3748/WJG.V8.I4.644
Subcellular daunorubicin distribution and its relation to multidrug resistance phenotype in drug-resistant cell line SMMC-7721/R.
Jia-yin Yang (2002)
10.1006/PEST.2001.2578
Basal Cellular Alterations of Esterase, Glutathione, Glutathione S-Transferase, Intracellular Calcium, and Membrane Potentials in Coumaphos-Resistant Boophilus microplus (Acari: Ixodidae) Cell Lines
R. Cossío-Bayúgar (2002)
Applications in Cancer
Shuming Nie (2007)
10.1039/B612903J
Synthesis and evaluation of caged Garcinia xanthones.
A. Batova (2007)
Synthesis and evaluation of dual-targeting uPA/NHE1 inhibitors from the K+-sparing diuretic amiloride
B. J. Buckley (2017)
10.1002/ijc.24825
BIIB021, a synthetic Hsp90 inhibitor, has broad application against tumors with acquired multidrug resistance
H. Zhang (2010)
Inhaled Nanopartcles: A Review
Koradiya Bhagirath (2012)
10.1002/APP.35613
A polymer–drug conjugate for doxorubicin: Synthesis and biological evaluation of pluronic F127‐doxorubicin amide conjugates
Qihe Gao (2011)
Estudo da Associação de Genes e Proteínas de Resistência a Múltiplos Fármacos (abcb1/ABCB1, abcc1/ABCC1 e lrp/LRP) com Marcadores Moleculares em Pacientes Portadores de Leucemias Agudas
Santos Vila da Silva (2013)
10.1002/jps.23706
Evaluating the roles of autophagy and lysosomal trafficking defects in intracellular distribution-based drug-drug interactions involving lysosomes.
Randall Logan (2013)
10.1002/mabi.201300339
pH- and redox-responsive poly(ethylene glycol) and cholesterol-conjugated poly(amido amine)s based micelles for controlled drug delivery.
Weiren Cheng (2014)
10.3109/1061186X.2013.839687
Recombinant lipoproteins reinforce cytotoxicity of doxorubicin to hepatocellular carcinoma
B. Wang (2014)
Cancer nanotechnology: engineering multifunctional nanostructures for targeting tumor cells and vasculatures
Gloria J. Kim (2007)
10.1111/j.1464-410X.2010.09794.x
Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management
M. Maruschke (2011)
10.1371/journal.pone.0035487
Overcoming Multidrug Resistance via Photodestruction of ABCG2-Rich Extracellular Vesicles Sequestering Photosensitive Chemotherapeutics
Vicky Goler‐Baron (2012)
10.1002/ijc.22098
Reversal of doxorubicin resistance in breast cancer cells by photochemical internalization
P. Lou (2006)
10.3109/1061186X.2014.958844
Nanoparticulate carriers: an emerging tool for breast cancer therapy
Priyanka Tharkar (2015)
ROLE OF NANOTECHNOLOGY IN CANCER THERAPY AND DIAGNOSIS
Anupama Bhadauria (2012)
Multielectrode platform for measuring oxygenation status in multicellular tumor spheroids
D. B. Sheth (2011)
10.1023/B:PHAM.0000012156.65125.01
Anticancer Drug Delivery with Transferrin Targeted Polymeric Chitosan Vesicles
C. Dufès (2004)
10.1111/jphp.12528
Chemosensitization of doxorubicin in multidrug‐resistant cells by unimolecular micelles via increased cellular accumulation and apoptosis
M. Wang (2016)
See more
Semantic Scholar Logo Some data provided by SemanticScholar